All In Biotech

Drug Trial Radar · NCT06010173

Evaluation of Gadopiclenol for Magnetic Resonance Imaging (MRI) in Japanese Adults and Children

Efficacy and Safety of Gadopiclenol for Magnetic Resonance Imaging (MRI) in Japanese Adults and Children

Last checked: Nov 20, 2026Latest source record: Jun 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 240 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

240

Actual

Start

Jul 21, 2023

Primary completion

May 6, 2025

Study completion May 6, 2025

Sponsor

Lead sponsor
GuerbetIndustry
Sponsor type
Industry
Collaborators
Bracco Imaging S.p.A.
First posted
Aug 24, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Crossover
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Diagnostic
FDA-regulated drug
No
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

GDX-44-014 - GDX-101 study was conducted in Japan including 2 cohorts (adult cohort for adult population and pediatric cohort for pediatric population), with different designs: * The adult cohort had a prospective, multi-center, randomized, double-blind, controlled, and cross-over design. * The pediatric cohort had a prospective, multi-center, non-randomized, open-label and single arm design. The primary objective was to demonstrate the non-inferiority of gadopiclenol-enhanced MRI at 0.05 mmol/kg body weight (BW) compared to gadobutrol-enhanced MRI at 0.1 mmol/kg BW in terms of lesion visualization for adult patients referred for contrast-enhanced MRI of Central Nervous System (CNS) or Body regions.

Conditions

  • Lesion in Body Region
  • CNS Lesion

Interventions

  • GadopiclenolDrug

    Dose/volume: Gadopiclenol administered was calculated based on patient's weight at the dose of 0.05 mmol/kg BW

  • Comparator (gadobutrol)Drug

    Dose/volume of comparator: Gadobutrol administered was calculated based on patient's weight at the dose of 0.1 mmol/kg BW.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Lesion Visualization on Paired Images: Border DelineationTime frame: At each MRI exam: the first MRI at Day 1 and the second MRI performed after a wash out period of 2 to 14 days (adult cohort)
  2. Lesion Visualization on Paired Images: Internal MorphologyTime frame: At each MRI exam: the first MRI at Day 1 and the second MRI performed after a wash out period of 2 to 14 days (adult cohort)
  3. Lesion Visualization on Paired Images: Degree of Contrast EnhancementTime frame: At each MRI exam: the first MRI at Day 1 and the second MRI performed after a wash out period of 2 to 14 days (adult cohort)

Locations

27 sites in 1 country. Site status is shown where the registry gives one.

  • Meitetsu Hospital

    Aichi, Japan

  • Fukuoka University Hospital

    Fukuoka, Japan

  • Gifu University Hospital

    Gifu, Japan

  • Gunma University Hospital

    Gunma, Japan

  • Hiroshima City Hiroshima Citizens Hospital

    Hiroshima, Japan

  • Nakamura Memorial Hospital

    Hokkaido, Japan

  • National Hospital Organization Shikoku Medical Center for Children and Adults

    Kagawa, Japan

  • Kanagawa Children's Medical Center

    Kanagawa, Japan

  • Kobe City Medical Center General Hospital

    Kobe, Japan

  • University Hospital, Kyoto Prefectural University of Medicine

    Kyoto, Japan

  • Kyoto City Hospital

    Kyoto, Japan

  • Tohoku University Hospital

    Miyagi, Japan

  • Nara Medical University Hospital

    Nara, Japan

  • Kawasaki Medical School Hospital

    Okayama, Japan

  • Osaka Metropolitan University Hospital

    Osaka, Japan

  • Tominaga Hospital

    Osaka, Japan

  • Saitama Prefectural Children's Medical Center

    Saitama, Japan

  • Shin-Kuki General Hospital

    Saitama, Japan

  • Shizuoka General Hospital

    Shizuoka, Japan

  • Hamamatsu University Hospital

    Shizuoka, Japan

  • Jichi Medical University Hospital

    Tochigi, Japan

  • Tokyo Shinagawa Hospital

    Tokyo, Japan

  • Toho University Omori Medical Center

    Tokyo, Japan

  • National Center for Child Health and Development

    Tokyo, Japan

  • Tokyo Metropolitan Children's Medical Center

    Tokyo, Japan

  • Kurobe City Hospital

    Toyama, Japan

  • Yamaguchi University Hospital

    Yamaguchi, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.